Advanced search
Publication Cover
Journal of Psychosocial Oncology Volume 38, 2020 - Issue 5
Submit an article Journal homepage
201
Views
4
CrossRef citations to date
0
Altmetric
Brief Reports

Baseline quality of life is associated with survival among people with advanced lung cancer

Mario J. Trejoa Department Epidemiology and Biostatistics, Mel & Enid Zuckerman College of Public Health, The University of Arizona, Tucson, Arizona, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4039-5169
, MPHORCID Icon,
Melanie L. Bella Department Epidemiology and Biostatistics, Mel & Enid Zuckerman College of Public Health, The University of Arizona, Tucson, Arizona, USAORCID Iconhttps://orcid.org/0000-0003-4821-4094
, PhDORCID Icon,
Haryana M. Dhillonb Centre for Medical Psychology and Evidence-Based Decision-Making, University of Sydney, Sydney, AustraliaORCID Iconhttps://orcid.org/0000-0002-6805-0261
, PhDORCID Icon &
Janette L. Vardyb Centre for Medical Psychology and Evidence-Based Decision-Making, University of Sydney, Sydney, Australia;c Concord Cancer Centre, Concord Repatriation General hospital, Concord, NSW, Australia;d Sydney Medical School, University of Sydney, Sydney, Australia
, PhD
Pages 635-641 | Published online: 15 May 2020

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Wang T, Nelson RA, Bogardus A, Grannis FW. Jr. Five-year lung cancer survival: which advanced stage nonsmall cell lung cancer patients attain long-term survival? Cancer. 2010;116(6):1518–1525. doi:10.1002/cncr.24871
  • Coates A, Porzsolt F, Osoba D. Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer. 1997;33(7):1025–1030. doi:10.1016/s0959-8049(97)00049-x
  • Efficace F, Bottomley A, Smit EF, et al. Is a patient’s self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Ann Oncol. 2006;17(11):1698–1704. doi:10.1093/annonc/mdl183
  • Langendijk H, Aaronson NK, de Jong JMA, ten Velde GPM, Muller MJ, Wouters M. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol. 2000;55(1):19–25. doi:10.1016/S0167-8140(00)00158-4
  • Lemonnier I, Guillemin F, Arveux P, et al. Quality of life after the initial treatments of non-small cell lung cancer: a persistent predictor for patients’ survival. Health Qual Life Outcomes. 2014;12(1):73. doi:10.1186/1477-7525-12-73
  • Movsas B, Hu C, Sloan J, et al. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial. JAMA Oncol. 2016;2(3):359–367. doi:10.1001/jamaoncol.2015.3969
  • Movsas B, Moughan J, Sarna L, et al. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. J Clin Oncol. 2009;27(34):5816–5822. doi:10.1200/JCO.2009.23.7420
  • Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer. 1994;30(5):635–642. doi:10.1016/0959-8049(94)90535-5
  • Dhillon HM, Bell ML, van der Ploeg HP, et al. Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: a randomized controlled trial. Ann Oncol. 2017;28(8):1889–1897. doi:10.1093/annonc/mdx205
  • Harrell FE, Jr, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the Yield of Medical Tests. JAMA. 1982;247(18):2543–2546. doi:10.1001/jama.1982.03320430047030
  • Vardy J, Dadasovich R, Beale P, Boyer M, Clarke SJ. Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials. BMC Cancer. 2009;9(1):130. doi:10.1186/1471-2407-9-130

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.